Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Crataegus oxyacantha is a medicinal plant, commonly known as hawthorn, used primarily as a cardiovascular tonic and as an herbal remedy for heart failure, hypertension, arrhythmias, and as a general antioxidative and anti-inflammatory agent[1][2][3]. Its cardioprotective activity appears to be due to a combination of mechanisms, including antioxidant effects, direct cardiotonic effects, mild vasodilation, antiarrhythmic, and anticholinesterase activity. Various compounds isolated from C. oxyacantha, such as flavonoids, oligomeric procyanidins, and triterpenic acids, have demonstrated inhibition of acetylcholinesterase and butyrylcholinesterase—enzymes involved in neurotransmission and linked to Alzheimer's disease[1]. It is also used to induce blood lipid reduction, has mild diuretic and nervine-sedative effects, and is generally reported as safe, with adverse effects rare and usually minor[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on crataegus oxyacantha.